Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Curr Med Res Opin ; 29(6): 611-21, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23514115

RESUMO

The diagnosis of multiple sclerosis (MS) is dependent on the presence of clinical and paraclinical evidence demonstrating dissemination of central nervous system lesions in both space and time, as well as the exclusion of other disorders. Diagnostic criteria were originally promulgated in 1965 by the Schumacher committee and modified subsequently by the Poser committee to include paraclinical evidence. The most recent criteria are the 2010 modifications of the 2001 McDonald criteria, which are focused on making an earlier diagnosis of MS. This article provides guidelines, derived from clinical experience as well as evidence-based medicine, for the diagnosis and management of MS with special emphasis on practices in the Middle East.


Assuntos
Imunossupressores/uso terapêutico , Esclerose Múltipla/diagnóstico , Esclerose Múltipla/terapia , Anticorpos Monoclonais Humanizados/uso terapêutico , Cloridrato de Fingolimode , Humanos , Interferon beta-1a , Interferon beta-1b , Interferon beta/uso terapêutico , Oriente Médio , Mielite/diagnóstico , Natalizumab , Doenças do Nervo Óptico/diagnóstico , Neurite Óptica/diagnóstico , Propilenoglicóis/uso terapêutico , Esfingosina/análogos & derivados , Esfingosina/uso terapêutico , Doenças da Medula Espinal/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA